Retatrutide (10mg)
$130.00
Retatrutide (10mg) is a multi-target triple agonist peptide engineered to hit GLP-1, GIP, and glucagon receptors. Designed to evaluate advanced weight loss and metabolic regulation, it delivers greater energy expenditure and appetite control in preclinical studies. High-purity lyophilized powder for laboratory research.
Size and packaging guidelines
Fermentum scelerisque hendrerit parturient nullam enim lobortis litora parturient dictumst.
Potenti a quisque tincidunt venenatis adipiscing parturient fermentum nisl tincidunt amentu.
Scelerisque conubia lobortis a condimentum ad eleifend dui integer maecenas habitant nostra.
| Specification | Chair | Armchair | Sofas |
| Height | 37" | 42" | 42" |
| Width | 26.5" | 32.5" | 142" |
| Depth | 19.5" | 22.5" | 24.5" |
| Assembly Required | No | No | Yes |
| Packaging Type | Box | Box | Box |
| Package Weight | 55 lbs. | 64 lbs. | 180 lbs. |
| Packaging Dimensions | 27" x 26" x 39" | 45" x 35" x 24" | 46" x 142" x 25" |
Retatrutide ( 10 mg) Ā (LY3437943) represents the next frontier in metabolic research. Unlike single- or dual-agonist peptides, Retatrutide is a single peptide molecule engineered with triple agonist activity at the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and Glucagon receptors.
This 10mg vial of ultra-pure Retatrutide powder is synthesized for advanced laboratory research studying energy expenditure, lipid oxidation, appetite regulation, and glycemic control. By simultaneously activating all three receptor pathways, Retatrutide demonstrates unmatched efficacy in metabolic and weight management research models.
Key Research Highlights & Scientific Mechanisms
Ā Triple Target Activation: Combines GLP-1 appetite suppression, GIP nutrient partitioning, and Glucagon-driven caloric expenditure.
Ā Enhanced Thermogenesis & Energy Expenditure: Glucagon receptor agonism directly targets hepatic fat metabolism and increases basal metabolic rate.
Ā Glycemic Control: Enhances glucose-dependent insulin secretion while blunting postprandial glucose spikes.
Ā Appetite & Satiety Regulation: Delays gastric emptying and signals central satiety pathways to reduce food intake.
Ā Visceral & Liver Fat Reduction: Promotes lipid clearance and reduces intra-hepatic fat accumulation in metabolic models.
Reconstitution & Storage Guidance
Ā Reconstitution: Slowly add sterile bacteriostatic water along the inside wall of the vial. Gently swirl until fully dissolvedādo not shake vigorously to avoid peptide denaturing.
Ā Storage: Store lyophilized powder sealed at -20Ā°C for long-term stability. Once reconstituted, keep liquid solutions refrigerated between 2Ā°C ā 8Ā°C (36Ā°F ā 46Ā°F) and shield from light.
Research Disclaimer: This product is sold strictly for laboratory research and development purposes. Not intended for direct human or veterinary administration.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoqueĀ dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueĀ vestibulum amet elit ut volutpat.
Related products
ARA-290 Peptide (16mg)
ARA-290 16 mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 16 mg of pure ARA-290 (Cibinetide; Pyroglu-Glu-Gln-Glu-Arg-Glu-Arg-Ala-Glu-Ala-Lys-Glu)āa 11-amino-acid synthetic peptide derived from the erythropoietin (EPO) structureāthis compound selectively targets the Innate Repair Receptor (IRR) without stimulating erythropoiesis. It is widely utilized in neurology, immunology, and tissue regeneration research investigating neuropathic pain attenuation, small nerve fiber regeneration, and inflammatory cytokine suppression.
Key Specifications
Active Compound: ARA-290 (Cibinetide / Pyroglutamate Helix B Surface Peptide)
Chemical Formula: \text{C}_{51}\text{H}_{84}\text{N}_{16}\text{O}_{21}
Concentration: 16 mg per vial
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Selective Innate Repair Receptor (IRR) Activation: ARA-290 selectively binds the erythropoietin receptor / \beta-common receptor (\text{EPOR/}\beta\text{cR}) heterodimer to initiate anti-inflammatory and tissue-protective signaling without increasing red blood cell count or hematocrit levels.
Small Fiber Neuropathy & Peripheral Nerve Repair: Extensively studied in neuropathic disease models for its ability to promote small nerve fiber density restoration, repair damaged peripheral axons, and relieve neuropathic pain signaling.
Anti-Inflammatory & Ischemic Protection: Investigated for its inhibitory effects on pro-inflammatory cytokine cascades (\text{TNF-}\alpha, \text{IL-6}) and its protective role against ischemia-reperfusion injury in cardiovascular and metabolic tissue models.
BPC-157 (10 mg)
BPC-157 (10mg) is a high-purity (ā„98%) research-grade pentadecapeptide extensively studied for its powerful tissue regeneration, tendon healing, and gut mucosa protective properties. Supplied as a stable lyophilized powder, every batch undergoes strict HPLC and Mass Spectrometry testing to guarantee maximum purity and reliable research results.
For research and laboratory use only. Not for human consumption.
Livagen Peptide (20mg)
Livagen peptide 20mg provides a high-purity, laboratory-verified lyophilized peptide manufactured under strict quality control standards in the USA. Formulated with 20 mg of pure Livagenāa synthetic peptide bioregulator closely related to Epitalon and composed of the peptide sequence Lys-Glu-Asp-Alaāthis compound is widely utilized in hepatology, molecular genetics, and biogerontology research examining chromatin decondensation, hepatic cellular protein synthesis, and immune modulation.
Key Specifications
Active Compound: Livagen (L-Lysyl-L-Glutamyl-L-Aspartyl-L-Alanine / Lys-Glu-Asp-Ala)
Chemical Formula: \text{C}_{18}\text{H}_{31}\text{N}_{5}\text{O}_{9}
Concentration: 20 mg per vial
Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Formulation: Sterile Lyophilized Powder
Origin: Manufactured in USA
Classification: Research Use Only
Primary Research Applications
Chromatin Activation & Epigenetic Regulation: Livagen is studied for its ability to induce decondensation of pericentromeric heterochromatin, reactivating silent genes associated with cellular aging and ribosomal RNA synthesis in senescent cells.
Hepatocyte Function & Liver Tissue Repair: Extensively evaluated in hepatic research models to observe its restorative effects on liver parenchyma, metabolic clearance mechanisms, and cellular detoxification enzymes.
Immune System Homeostasis: Investigated in immunogerontology models to assess T-lymphocyte function restoration, lymphocyte chromatin structure normalization, and resistance against toxic environmental stress.
Receptor Grade IGF-1 LR3 (1mg)
IGF-1 LR3 Receptor Grade 1 mg provides a high-purity, laboratory-verified lyophilized recombinant peptide manufactured under strict quality control standards in the USA. Formulated with 1 mg of pure Long \text{R}^3 Insulin-like Growth Factor-1, this modified analog features an arginine substitution at position 3 and a 13-amino-acid N-terminal extension. Specifically designated as receptor grade, this compound exhibits significantly reduced binding affinity for IGF binding proteins (IGFBPs), allowing researchers to study prolonged, uninhibited receptor-ligand interactions and cellular proliferation dynamics.
Key Specifications
Ā Active Compound: IGF-1 LR3 (Long Arginine 3 IGF-1)
Ā Grade: Receptor Grade
Ā Concentration: 1 mg per vial
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā IGFBP Resistance & Extended Half-Life: The structural modification drastically lowers binding to IGF-binding proteins, enabling researchers to observe sustained activation of the IGF-1 receptor (IGF-1R) without rapid metabolic inactivation.
Ā Cellular Proliferation & Protein Synthesis: Widely applied in vitro to study MAPK/ERK and PI3K/Akt/mTOR signaling pathways involved in cell growth, myogenesis, and nutrient transport regulation.
Ā Hyperplasia & Tissue Culture Assays: Utilized in research models measuring satellite cell activation, skeletal muscle fiber recruitment, and metabolic shift mechanics.
Semaglutide 5 mg
Semaglutide 5 mg is a research-grade lyophilized peptide engineered for high-purity laboratory applications. Each vial contains 5 mg of HPLC-verified Semaglutide, third-party tested to guarantee over 99% purity and manufactured in the USA under strict quality standards. Formulated specifically for research investigating GLP-1 receptor activation, glucose-dependent insulin secretion, gastric emptying regulation, and metabolic homeostasis pathways, this product is strictly intended for research use only.
Semax (25mg)
Semax (25mg) is a premium research-grade synthetic heptapeptide (ā„98% purity) studied for its potent neuroprotective, memory-enhancing, and BDNF-boosting properties. Supplied as a stable, lyophilized powder, every batch is HPLC and Mass Spectrometry verified to ensure maximum purity and consistency for laboratory investigation.
For research and laboratory use only. Not for human consumption.
Tesamorelin & Ipamorelin Blend (8mg)
Tesamorelin 6 mg / Ipamorelin 2 mg is a research-grade lyophilized peptide blend engineered for high-purity laboratory applications. Each vial contains an 8 mg total blend (6 mg Tesamorelin / 2 mg Ipamorelin), third-party HPLC-tested to guarantee over 99% purity and manufactured in the USA under strict standards. Formulated specifically for research investigating dual GHRH and GHSR receptor activation, visceral fat metabolism, and endocrine signaling pathways, this product is strictly intended for research use only.
Tirzepatide (5mg)
Tirzepatide (5mg) is a dual GIP and GLP-1 receptor agonist designed to study advanced weight loss, lipid metabolism, and glycemic control. Engineered for high potency, this peptide targets dual incretin pathways to optimize metabolic research outcomes. Supplied as a high-purity lyophilized powder for laboratory use.
Reviews
There are no reviews yet.